suramin sodium has been researched along with nifurtimox in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Howarth, J; Wilson, D | 1 |
| Caffrey, CR; Glaser, M; Hansell, E; Hoerr, V; Holzgrabe, U; McKerrow, JH; Moll, H; Ponte-Sucre, A; Schirmeister, T; Schultheis, M; Stich, A; Vicik, R | 1 |
2 other study(ies) available for suramin sodium and nifurtimox
| Article | Year |
|---|---|
1,4-Dihydroxy-2,3-dioxatricyclo[8.4.0.0(4,9)]tetradecane and derivatives with in vitro activity against Plasmodium falciparum, Trypanasoma b brucei, Trypanasoma cruzi, and Leishmaniasis infantum.
Topics: Alkanes; Animals; Antiprotozoal Agents; Bridged-Ring Compounds; Cell Line; Humans; Inhibitory Concentration 50; Leishmania infantum; Plasmodium falciparum; Structure-Activity Relationship; Trypanosoma brucei brucei; Trypanosoma cruzi | 2003 |
Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents.
Topics: Animals; Antiprotozoal Agents; Carboxylic Acids; Cysteine Proteinase Inhibitors; Trypanosoma brucei brucei | 2006 |